149,920 members

Skip to content. | Skip to navigation

News

Cancer drug for children recommended after becoming cost effective for NHS patients

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

Cancer drug for children recommended after becoming cost effective for NHS patients

Seriously ill children battling high-risk neuroblastoma, a rare type of cancer that mainly affects children and young people, are to be offered a drug which has potential to extend their lives.

Around 60% of children with high-risk neuroblastoma could be treated with dinutuximab beta.

A National Institute for Health and Care Excellence (NICE) appraisal committee has recommended dinutuximab beta in final draft technology appraisal guidance.